Boehringer Reflects On Resilience Of Older Therapies

As Early-Stage Oncology Pipeline Advances

 
• By Kevin Grogan
  
golden eggs
Spiriva, Pradaxa And Trajenta still big-earners for Boehringer
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business